Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R
- 10 April 2014
- journal article
- Published by American Society of Hematology in Blood
- Vol. 123 (15) , 2333-2342
Abstract
Key Points: Disease relapse is a common cause of failure of allogeneic hematopoietic stem cell transplantation in patients with advanced MDS. High IPSS-R prognostic risk category and monosomal karyotype are independent predictors of relapse after allogeneic transplantation in MDS.Keywords
This publication has 35 references indexed in Scilit:
- The genetic basis of myelodysplasia and its clinical relevanceBlood, 2013
- Clinical and biological implications of driver mutations in myelodysplastic syndromesBlood, 2013
- Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNetBlood, 2013
- Clonal Architecture of Secondary Acute Myeloid LeukemiaNew England Journal of Medicine, 2012
- Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasmsBlood, 2011
- SomaticSF3B1Mutation in Myelodysplasia with Ring SideroblastsNew England Journal of Medicine, 2011
- Frequent pathway mutations of splicing machinery in myelodysplasiaNature, 2011
- Clinical Effect of Point Mutations in Myelodysplastic SyndromesNew England Journal of Medicine, 2011
- Proposal for a new risk model in myelodysplastic syndrome that accounts for events not considered in the original International Prognostic Scoring SystemCancer, 2008
- Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic SyndromesJournal of Clinical Oncology, 2007